Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2018.1529385
Abstract: Abstract Background: It is important to determine the vasoconstrictor potencies of topical corticosteroids used to treat psoriasis to ensure appropriate clinical use. Objective: To compare the vasoconstrictive potencies of fixed-dose combination calcipotriol (50 μg/g) and betamethasone… read more here.
Keywords: topical corticosteroids; foam; used treat; corticosteroids used ... See more keywords
Repurposing anthelmintic praziquantel to treat psoriasis.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of pharmacology"
DOI: 10.1111/bph.15652
Abstract: BACKGROUND AND PURPOSE The anthelmintic drug praziquantel (PZQ) has been used as a standard treatment for schistosomiasis for over 40 years. This study aimed to repurpose PZQ to treat psoriasis. EXPERIMENTAL APPROACH Psoriasis-like skin inflammation… read more here.
Keywords: stat3 phosphorylation; praziquantel; psoriasis; treat psoriasis ... See more keywords